Merkel cell carcinoma: A systematic review of the demographic and clinical characteristics of 847 cases in Japan.
Japanese
Merkel cell carcinoma
Merkel cell polyomavirus
retrospective studies
risk factors
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
revised:
07
03
2021
received:
19
08
2020
accepted:
14
03
2021
pubmed:
14
4
2021
medline:
6
7
2021
entrez:
13
4
2021
Statut:
ppublish
Résumé
Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine carcinoma of the skin associated with Merkel cell polyomavirus and immunosuppression. Although MCC incidence is rising worldwide, MCC has not been sufficiently investigated in Japan. This study aimed to determine MCC demographics in Japan, including incidence, age, sex, location, spontaneous regression, and pure/combined MCC. Using PubMed and Igaku Chuo Zasshi, 847 MCC cases between 1985 and 2015 were extracted, and the main epidemiological characteristics were described. The mean age of all patients was 77.5 years. Regarding the characterized lesions, 63.0% were located on the head and neck, 5.2% on the trunk, 12.6% on the upper limb, 15.1% on the lower limb, 3.5% on the buttocks, and 0.6% on the genitals. Histopathological information regarding the presence of other malignancies could be retrieved in 611 cases, and a coexisting malignancy, mainly squamous cell carcinoma and Bowen's disease, was present in 14.2%. Subcutaneous MCC was observed in 31 patients with a male : female ratio of 1.07 (16 men/15 women). Nodal lesions with unknown primary tumor location were described in 19 patients with a male : female ratio of 0.9 (nine men/10 women) and a mean age of 77.7 years. Of 640 evaluable cases, spontaneous regression developed in 9.1%. Among those 58 patients, the male : female ratio was 1:2.1 in 56 evaluable cases (18 men/38 women). Merkel cell polyomavirus was assessed in 180 patients, and the virus was detected in 31.1% and not detected in 68.9% of the patients. MCC is a rare disease in Japan, with incidence rates and male : female ratios differing from those in the USA and European countries. Besides, this study reveals the high frequency of subcutaneous MCC and MCC with divergent differentiation patterns and spontaneous regression in Japan compared to other countries.
Identifiants
pubmed: 33847013
doi: 10.1111/1346-8138.15875
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1027-1034Informations de copyright
© 2021 Japanese Dermatological Association.
Références
Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78:457-463.e2.
Kieny A, Cribier B, Meyer N, Velten M, Jégu J, Lipsker D. Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France. Int J Cancer. 1985;144:741-5.
Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol. 2002;20:588-98.
Chang Y, Moore PS. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol. 2012;7:123-44.
Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096-100.
Stakaityte G, Wood JJ, Knight LM, Abdul-Sada H, Adzahar NS, Nwogu N, et al. Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus. Cancers (Basel). 2014;6:1267-97.
Brady MS. Current management of patients with merkel cell carcinoma. Dermatol Surg. 2004;30:321-5.
Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Advances in anatomic pathology. 2009;16:135-44.
Becker JC, Houben R, Ugurel S, Trefzer U, Pföhler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol. 2009;129:248-50.
Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol. 2009;129:246-8.
Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37:20-7.
Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58:375-81.
Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113:2549-58.
Ono T, Kayashima K, Maruo K. Merkel cell carcinoma in Japan. In: Suzuki H, Ono T, editors. Merkel cells, Merkel cell carcinoma and neurobiology of the skin. Excerpta Medical International Series 1187. Amsterdam: Elsevier Science BV; 2000.
Matsuda T, Sobue T. Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry. Int J Clin Oncol. 2015;20:11-20.
Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol. 2014;150:864-72.
Kukko H, Bohling T, Koljonen V, Tukiainen E, Haglund C, Pokhrel A, et al. Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer. 2012;48:737-42.
Koljonen V. Merkel cell carcinoma. World J Surg Oncol. 2006;4:7.
Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49:832-41.
Grabowski J, Saltzstein SL, Sadler GR, Tahir Z, Blair S. A comparison of merkel cell carcinoma and melanoma: results from the California Cancer Registry. Clin Med Oncol. 2008;2:327-33.
Robertson JP, Liang ES, Martin RC. Epidemiology of Merkel cell carcinoma in New Zealand: a population-based study. Br J Dermatol. 2015;173:835-7.
Fleming KE, Ly TY, Pasternak S, Godlewski M, Doucette S, Walsh NM. Support for p63 expression as an adverse prognostic marker in Merkel cell carcinoma: report on a Canadian cohort. Hum Pathol. 2014;45:952-60.
Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst. 2010;102:793-801.
Pectasides D, Pectasides M, Economopoulos T. Merkel cell cancer of the skin. Ann Oncol. 2006;17:1489-95.
Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol. 2004;5:593-9.
Melnik Y, Slater PE, Steinitz R, Davies AM. Breast cancer in Israel: laterality and survival. J Cancer Res Clin Oncol. 1979;95:291-3.
Weiss NS, Silverman DT. Laterality and prognosis in ovarian cancer. Obstet Gynecol. 1977;49:421-3.
Amer MH. Genetic factors and breast cancer laterality. Cancer Manag Res. 2014;6:191-203.
Brewster DH, de Vries E. Left-sided excess of invasive cutaneous melanoma. J Am Acad Dermatol. 2011;65:207-8.
Dores GM, Huycke MM, Devesa SS. Melanoma of the skin and laterality. J Am Acad Dermatol. 2011;64:193-5.
Paulson KG, Iyer JG, Nghiem P. Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2011;65:35-9.
Gambichler T, Wieland U, Silling S, Dreissigacker M, Schaller J, Schulze HJ, et al. Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure. J Cancer Res Clin Oncol. 2017;143:347-50.
Koljonen V, Kluger N, Sihto H, Bohling T. Lateral distribution of Merkel cell carcinoma in a nationwide cohort. J Eur Acad Dermatol Venereol. 2013;27:884-8.
Stokes JB, Graw KS, Dengel LT, Swenson BR, Bauer TW, Slingluff CL Jr, et al. Patients with Merkel cell carcinoma tumors < or =1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol. 2009;27:3772-7.
Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Kraus DH, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529-37.
Schwartz JL, Griffith KA, Lowe L, Wong SL, McLean SA, Fullen DR, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011;29:1036-41.
Kukko HM, Koljonen VS, Tukiainen EJ, Haglund CH, Bohling TO. Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Mod Pathol. 2010;23:1151-6.
Acebo E, Vidaurrazaga N, Varas C, Burgos-Bretones JJ, Diaz-Perez JL. Merkel cell carcinoma: a clinicopathological study of 11 cases. J Eur Acad Dermatol Venereol. 2005;19:546-51.
Jaeger T, Ring J, Andres C. Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status. J Skin Cancer. 2012;2012:983421.
Nghiem P, Jaimes N. Merkel cell carcinoma. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine, 7th edn. Madrid: Editorial Panamericana, 2008. p. 1087-94.
Calonge E. Merkel cell carcinoma. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology, 8th edn. Oxford: Wiley-Blackwell, 2010. P. 42-4.
Nagase K, Kimura-Kaku H, Inoue T, Shinogi T, Narisawa Y. Usefulness of ulceration and hyperkeratosis as clinical predictors of Merkel cell polyomavirus-negative and combined Merkel cell carcinoma: A retrospective study. J Dermatol. 2019;46:103-9.
Balaton AJ, Capron F, Baviera EE, Meyrignac P, Vaury P, Vuong PN. Neuroendocrine carcinoma (Merkel cell tumor?) presenting as a subcutaneous tumor. An ultrastructural and immunohistochemical study of three cases. Pathol Res Pract. 1989;184:211-6.
Gambichler T, Kobus S, Kreuter A, Wieland U, Stucker M. Primary merkel cell carcinoma clinically presenting as deep oedematous mass of the groin. Eur J Med Res. 2010;15:274-6.
Garcia-Rabasco A, Esteve-Martinez A, Marin-Bertolin S, Alegre-de-Miquel V. Panniculitic merkel cell carcinoma: report of a case and literature review. Dermatol Surg. 2012;38:1395-9.
Huang GS, Chang WC, Lee HS, Taylor JA, Cheng TY, Chen CY. Merkel cell carcinoma arising from the subcutaneous fat of the arm with intact skin. Dermatol Surg. 2005;31:717-9.
Hyer SL, McAleese J, Harmer CL. Neuroendocrine carcinoma arising in soft tissue: three case reports and literature review. World J Surg Oncol. 2007;5:77.
Boutilier R, Desormeau L, Cragg F, Roberts P, Walsh N. Merkel cell carcinoma: squamous and atypical fibroxanthoma-like differentiation in successive local tumor recurrences. Am J Dermatopathol. 2001;23:46-9.
Foote M, Veness M, Zarate D, Poulsen M. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol. 2012;67:395-9.
Copeland EM, McBride CM. Axillary metastases from unknown primary sites. Ann Surg. 1973;178:25-7.
Hainsworth JD, Wright EP, Johnson DH, Davis BW, Greco FA. Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining. J Clin Oncol. 1991;9:1931-8.
Spigel DR, Hainsworth JD, Greco FA. Neuroendocrine carcinoma of unknown primary site. Semin Oncol. 2009;36:52-9.
Vandeven N, Lewis CW, Makarov V, Riaz N, Paulson KG, Hippe D, et al. Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival. Clin Cancer Res. 2018;24:963-71.
Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011;254:465-73.
Kotteas EA, Pavlidis N. Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: management and outcomes of a rare entity. Crit Rev Oncol Hematol. 2015;94:116-1121.